Funding Guidance and Technical Assistance to States

Photo of first responder being vaccinated. Congress authorized funding for the Public Health Emergency Preparedness (PHEP) cooperative agreement to support preparedness nationwide in state, local, tribal, and territorial public health departments in 2002, shortly after the events of September 11, 2001, and subsequent anthrax attacks. The PHEP cooperative agreement provides funding to enable public health departments to have the capacity and capability to effectively respond to the public health consequences of not only terrorist threats, but also infectious disease outbreaks, natural disasters, and biological, chemical, nuclear, and radiological emergencies. These emergency preparedness and response efforts are designed to support the National Response Framework (NRF) and the National Incident Management System (NIMS) and are targeted specifically for the development of emergency-ready public health departments.

CDC provides PHEP cooperative agreement funding to 62 grantees, which include 50 states, eight territories (Puerto Rico, the Virgin Islands, American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Republic of the Marshall Islands, Republic of Palau, and the Federated States of Micronesia), and four metropolitan areas (Washington, D.C., Chicago, Los Angeles County and New York City). CDC's Office of Public Health Preparedness and Response, Division of State and Local Readiness, administers the PHEP cooperative agreement and works closely with subject matter experts across CDC to provide annual guidance and technical assistance to state, territorial, and major metropolitan public health departments.

Public Health Emergency Preparedness (PHEP) Cooperative Agreement

2010 Guidance/Budget Period 10 Extension

Program Announcement AA154 - FY 2010 (Budget Period 10 Extension)
- PHEP BP10 Extension Guidance (679 KB/65pages)
- PHEP BP10 Extension Guidance Version Formatted for Section 508 (586 KB/63 pages)
- BP10 Extension Guidance Summary of Changes (125 KB/2 pages)
- Revised Funding Table – August 2010 (93 KB/3 pages)

2009 Guidance/Budget Period 10

Program Announcement AA154 - FY 2009 (Budget Period 10)
- Download the Program Announcement (340 KB/58 pages)
- Download the Version Formatted for Section 508 (506 KB/60 pages)

PHEP Performance Measures Guidance

Download the Full Guidance Formatted for Section 508 (718 KB/82 pages)

High Priority Performance Goal (HPPG) for Preparedness

HPPG Contextual Indicators Comparison

2004-2008 Guidance PHEP Archive

Archive — guidance and technical assistance documents from past years.

Public Health Emergency Response (PHER) Grant

Congress appropriated funding in June 2009 through the 2009 Supplemental Appropriations Act for the “Public Health and Social Services Emergency Fund” to prepare for and respond to an influenza pandemic. This funding provides the Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and other federal and state agencies with resources to respond to ongoing and emerging outbreaks of novel H1N1 influenza in the United States. To date, CDC is administering $1.35 billion through the Public Health Emergency Response (PHER) grant to upgrade state and local pandemic influenza preparedness and response capacity. The 62 awardees include 50 states, 8 territories and freely associated states, and 4 localities (Chicago, Illinois; Los Angeles County, California; New York City, New York; and Washington, D.C.).

PHER Phase I

Funding is being distributed in phases. Phase I funding of $260 million is intended to help PHER awardees assess their current capabilities in pandemic influenza response and to address remaining gaps in two focus areas as described below. This funding has been allocated using a population-based funding formula, with funds awarded beginning July 31, 2009.

Focus Area 1: $195 million - Vaccination, Antiviral Distribution/Dispensing and Administration, and Community Mitigation Activities
Focus Area 2: $65 million - Laboratory, Epidemiology, Surveillance Activities

Phase I guidance

(193K, 21 page)

PHER Phase II

An additional $248 million in PHER Phase II funding has been released to supplement the original $260 million and is intended to provide additional resources for mass vaccination planning and implementation preparedness activities. Phase II funding also may be used for vaccine delivery, vaccine administration, and related communications planning and implementation. Phase II funds have been allocated using a base-plus-population formula, with funds awarded beginning August 21, 2009.

Phase II guidance (152K, 14 page)

PHER Phase III

A total of $846 million in PHER Phase III funding has been awarded for implementation of the 2009 H1N1 influenza mass vaccination campaign, expected to begin in October, at the state, local, tribal, and territorial levels. Phase III funds have been allocated using a base-plus-population formula, with 100% of the funds available immediately beginning September 28, 2009.

Phase III guidance (154K, 13 page)

PHER Phase IV

A total of $49.7 million in PHER Phase IV funding has been awarded to 15 states and localities to complete their H1N1 vaccination programs, specifically targeting high-risk populations, minority and hard-to-reach populations, and underserved and vulnerable populations that may have been unable to access vaccination services previously. Phase IV funds have been allocated using a base-plus-population formula, with 100% of the funds available beginning March 18.

Phase IV guidance (246K, 23 page)